SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18292396
Source:
http://linkedlifedata.com/resource/pubmed/id/18292396
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0040690
,
umls-concept:C0165519
,
umls-concept:C0221464
,
umls-concept:C1705294
,
umls-concept:C1879547
pubmed:issue
5
pubmed:dateCreated
2008-4-18
pubmed:abstractText
Isolated systolic hypertension is associated with increased elastase activity, vascular calcification, and vascular stiffness. We sought to determine the importance of elastase activity and matrix degradation in the development of elastocalcinosis.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9505803
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Collagen
,
http://linkedlifedata.com/resource/pubmed/chemical/Durapatite
,
http://linkedlifedata.com/resource/pubmed/chemical/Elastin
,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9
,
http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin
,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
,
http://linkedlifedata.com/resource/pubmed/chemical/Warfarin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1524-4636
pubmed:author
pubmed-author:BlanchetteJoannieJ
,
pubmed-author:BouvetCélineC
,
pubmed-author:MoreauPierreP
,
pubmed-author:MoreauSimonS
,
pubmed-author:de BloisDenisD
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
856-62
pubmed:meshHeading
pubmed-meshheading:18292396-Animals
,
pubmed-meshheading:18292396-Aorta, Abdominal
,
pubmed-meshheading:18292396-Calcinosis
,
pubmed-meshheading:18292396-Collagen
,
pubmed-meshheading:18292396-Disease Models, Animal
,
pubmed-meshheading:18292396-Durapatite
,
pubmed-meshheading:18292396-Elastin
,
pubmed-meshheading:18292396-Femoral Artery
,
pubmed-meshheading:18292396-Male
,
pubmed-meshheading:18292396-Matrix Metalloproteinase 9
,
pubmed-meshheading:18292396-Osteopontin
,
pubmed-meshheading:18292396-Rats
,
pubmed-meshheading:18292396-Rats, Wistar
,
pubmed-meshheading:18292396-Signal Transduction
,
pubmed-meshheading:18292396-Transforming Growth Factor beta
,
pubmed-meshheading:18292396-Vascular Diseases
,
pubmed-meshheading:18292396-Warfarin
pubmed:year
2008
pubmed:articleTitle
Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis.
pubmed:affiliation
Faculty of Pharmacy, Université de Montréal, Québec, Canada.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't